checkAd

     1680  0 Kommentare The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against HeartWare International Inc. - HTWR

    NEW ORLEANS, LA--(Marketwired - February 05, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 22, 2016 to file lead plaintiff applications in a securities class action lawsuit against HeartWare International Inc. (NASDAQ: HTWR), if they purchased the Company's securities between June 10, 2014 and January 11, 2016, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

    What You May Do

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Barrick Gold Corporation!
    Long
    15,25€
    Basispreis
    1,84
    Ask
    × 7,88
    Hebel
    Short
    18,97€
    Basispreis
    1,85
    Ask
    × 7,67
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    If you purchased shares of HeartWare and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by March 22, 2016.

    About the Lawsuit

    HeartWare and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

    On September 9, 2015, HeartWare disclosed that it was halting enrollment in the trial for MVAD, a pump that it was developing, because of a manufacturing problem. Thereafter, on October 12, 2015, HeartWare disclosed that patients had suffered adverse events and the trial would be further delayed. Finally, on January 11, 2016, HeartWare revealed that approximately half of the patients implanted with the MVAD experienced serious adverse events and the trial would be delayed indefinitely. Following these announcements, the price of HeartWare's stock plummeted. 

    About Kahn Swick & Foti, LLC

    KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

    To learn more about KSF, you may visit www.ksfcounsel.com.

    Contact:
    Kahn Swick & Foti, LLC
    Lewis Kahn
    Managing Partner
    lewis.kahn@ksfcounsel.com
    1-877-515-1850
    206 Covington St.
    Madisonville, LA 70447



    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Marketwired
    The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against HeartWare International Inc. - HTWR NEW ORLEANS, LA--(Marketwired - February 05, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 22, 2016 to file lead plaintiff …

    Schreibe Deinen Kommentar

    Disclaimer